Related Experiment Video
Updated: Apr 23, 2026

Induction and Diagnosis of Tumors in Drosophila Imaginal Disc Epithelia
Published on: July 25, 2017
SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression
Junji Otani1,2, Miki Nishio1, Riko Tokita1
1Division of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Japan.
Abstract:
The transcriptional cofactors YAP1 and TAZ regulate target gene expression by binding to the transcription factor TEAD. Due to their roles in cancer initiation, progression, and drug resistance, YAP1 and TAZ are promising targets for cancer therapy. SAMD4A/B are RNA-binding proteins that are broadly expressed across human tissues, but few of their molecular targets and biological functions have been identified. In Drosophila, the SAMD4A/B homolog Smaug participates in early embryonic development by disrupting the stability and translation of maternal mRNA. To discover targets inhibiting the YAP1/TAZ-TEAD oncogenic transcription program, we screened a whole-genome siRNA library and identified siSAMD4B as potently suppressing TEAD activity in human cancer cells. We showed that SAMD4A/B increased TEAD activity by destabilizing and repressing the translation of VGLL4 mRNA, promoting cancer progression in vitro. Conversely, inhibiting either SAMD4A or SAMD4B elevated VGLL4 mRNA, which suppressed TEAD activity and inhibited cancer progression. Notably, transgenic mice expressing liver-specific SAMD4B exhibited accelerated development of intrahepatic cholangiocarcinomas in an Nf2-deficient background. These tumors appeared in the mutants at one week of age and caused death due to hepatic failure by 100 days. Thus, SAMD4A/B may be a promising target for anticancer drugs designed to inhibit TEAD activation.
Insights
SAMD4A/B proteins promote cancer by destabilizing VGLL4 mRNA, which activates YAP1/TAZ-TEAD transcription. Inhibiting SAMD4A/B boosts VGLL4, suppressing cancer progression and TEAD activity.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- YAP1 and TAZ are transcriptional cofactors that bind TEAD, driving cancer initiation, progression, and drug resistance.
- SAMD4A/B are RNA-binding proteins with largely unknown functions; their Drosophila homolog Smaug affects mRNA stability and translation.
- The YAP1/TAZ-TEAD pathway is a critical therapeutic target in oncology.
Purpose of the Study:
- To identify novel targets that inhibit the YAP1/TAZ-TEAD oncogenic transcription program.
- To investigate the role of SAMD4A/B proteins in regulating YAP1/TAZ-TEAD activity and cancer progression.
Main Methods:
- Whole-genome siRNA library screening to identify suppressors of TEAD activity.
- Assessing the impact of SAMD4A/B on VGLL4 mRNA stability and translation.
- In vitro cell-based assays for cancer progression.
- In vivo studies using transgenic mice with liver-specific SAMD4B expression.
Main Results:
- siSAMD4B potently suppressed TEAD activity in human cancer cells.
- SAMD4A/B destabilize and repress VGLL4 mRNA translation, thereby promoting cancer progression.
- Inhibition of SAMD4A/B increased VGLL4 mRNA, suppressed TEAD activity, and inhibited cancer progression.
- Liver-specific SAMD4B expression accelerated intrahepatic cholangiocarcinoma development in Nf2-deficient mice.
Conclusions:
- SAMD4A/B promote cancer progression by negatively regulating VGLL4 mRNA, leading to YAP1/TAZ-TEAD pathway activation.
- SAMD4A/B represent a promising therapeutic target for developing anticancer drugs that inhibit TEAD activation.
More Related Videos
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Loss of Tumor Suppressor Gene Functions
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
MicroRNAs
MicroRNAs